Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study
Clinical trial NCT07481032 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07481032
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2028-04-01
- Enrollment
- 1034
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.